Evidence map›Paper›PMID 37745515›Full record

ArticlebioRxiv : the preprint server for biology2023

Plasma membrane abundance dictates phagocytic capacity and functional crosstalk in myeloid cells.

Benjamin Y Winer, Alexander H Settle, Alexandrina M Yakimov, Carlos Jeronimo, Tomi Lazarov, Murray Tipping, Michelle Saoi, Anjelique Sawh, Anna-Liisa L Sepp, Michael Galiano and 11 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Benjamin Y WinerImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Alexander H SettleImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Alexandrina M YakimovImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Carlos JeronimoImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Tomi LazarovImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Murray TippingImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Michelle SaoiImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Anjelique SawhNew York Structural Biology Center; New York, NY, USA.
Anna-Liisa L SeppDepartment of Biomedical Engineering, Columbia University; New York, NY, USA.
Michael GalianoImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Yung Yu WongImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Justin S A PerryImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Frederic GeissmannImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Justin CrossImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Ting ZhouImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Lance C KamDepartment of Biomedical Engineering, Columbia University; New York, NY, USA.
Hilda Amalia PasoliElectron Microscopy Resource Center, The Rockefeller University; New York, NY, USA.
Tobias HohlImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Jason G CysterDepartment of Microbiology and Immunology, University of California San Francisco; San Francisco, CA, USA.
Orion D WeinerCardiovascular Research Institute, University of California San Francisco; San Francisco, CA, USA.
Morgan HuseImmunology Program, Memorial Sloan Kettering Cancer Center; New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USNew York Proton Center · USHoward Hughes Medical Institute · USNew York Structural Biology Center · USUniversity of California, San Francisco · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Cellular Decision Making Diversity SupplementR35GM118167 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Orion D Weiner · 2016 to 2026
$10.3M
Synaptic Control of Cytotoxic T cell FunctionR01AI087644 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI HUSE, MORGAN A · 2010 to 2025
$7.3M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI087644NIGMS NIH HHS R35 GM118167
6 · The paper itself

Abstract

Professional phagocytes like neutrophils and macrophages tightly control what they eat, how much they eat, and when they move after eating. We show that plasma membrane abundance is a key arbiter of these cellular behaviors. Neutrophils and macrophages lacking the G-protein subunit Gb4 exhibit profound plasma membrane expansion due to enhanced production of sphingolipids. This increased membrane allocation dramatically enhances phagocytosis of bacteria, fungus, apoptotic corpses, and cancer cells. Gb4 deficient neutrophils are also defective in the normal inhibition of migration following cargo uptake. In Gb4 knockout mice, myeloid cells exhibit enhanced phagocytosis of inhaled fungal conidia in the lung but also increased trafficking of engulfed pathogens to other organs. These results reveal an unexpected, biophysical control mechanism lying at the heart of myeloid functional decision-making.

Identifiers

PMID37745515
PMCPMC10515848
OpenAlexW4386707866

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.